Dexcom rtCGM Can Be Easily Prescribed on Most EMR Systems in Canada
Dexcom real-time Continuous Glucose Monitoring (rtCGM) systems can be quickly and easily prescribed through most electronic medical record (EMR) systems used in Canada. This allows healthcare providers to streamline their workflow while significantly improving the quality of care for people living with diabetes.
Easily Prescribe Dexcom for Enhanced Diabetes Management
Dexcom rtCGM is clinically proven to help lower A1C, increase time in range, and lead to better glycemic outcomes for individuals with type 1 or type 2 diabetes1-5 —with no routine fingersticks or scanning.* 95% of endocrinologists agree that rtCGM, like Dexcom G7, is the standard of care for people living with type 1 diabetes.6
To help individuals better manage their condition, Dexcom rtCGM systems can be seamlessly prescribed through most EMRs used across Canada—now including TELUS Health EMR systems such as PS Suite.
EMR Improves Productivity, Efficiency, and Quality of Care
Electronic Medical Records (EMRs) provide a simple and fast way for healthcare providers to manage an individual’s personal health information, support patient care in person and remotely, and improve clinic workflow and processes. EMR systems are also the most efficient way to prescribe medications and healthcare tools, like Dexcom rtCGM.
How to Prescribe Dexcom rtCGM Through EMR
Using an EMR to prescribe Dexcom rtCGM is quick and seamless. Simply add the Dexcom CGM prescription form to your system and select it in your patient’s profile account when prescribing.
The exact prescription process varies depending on the type of EMR you use. Refer to the Dexcom EMR Reference Guide for a complete list of compatible EMRs and detailed step-by-step prescription instructions for each.
Questions about the prescription process? Request a call with the Dexcom support team.
*If glucose alerts and readings from the Dexcom CGM System do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
1 Beck RW, et al. JAMA. 2017;317(4):371-378.
2 Beck RW, et al. Ann Intern Med. 2017;167(6):365-374.
3 Martens T, et al. JAMA. 2021;325(22):2262-2272.
4 Laffel LM, et al. JAMA. 2020;323(23):2388-2396.
5 Welsh JB, et al. Comparisons of Fifth-, Sixth-, and Seventh-Generation Continuous Glucose Monitoring Systems. J Diabetes Sci Technol. 2024;18(1):143-7.
6 Dexcom, Data on file, 2022.
MAT-2471 V1.0